Disease-associated prion protein oligomers inhibit the 26S proteasome

被引:214
作者
Kristiansen, Mark
Deriziotis, Pelagia
Dimcheff, Derek E.
Jackson, Graham S.
Ovaa, Huib
Naumann, Heike
Clarke, Anthony R.
van Leeuwen, Fijs W. B.
Menendez-Benito, Victoria
Dantuma, Nico P.
Portis, John L.
Collinge, John
Tabrizi, Sarah J.
机构
[1] UCL, Neurol Inst, Dept Neurodegenerat Dis, London WC1N 3BG, England
[2] UCL, MRC, Prion Unit, London WC1N 3BG, England
[3] NIAID, Lab Persistant Viral Dis, NIH, Rocky Mt Labs, Hamilton, MT 59840 USA
[4] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands
[5] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.molcel.2007.04.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism of cell death in prion disease is unknown but is associated with the production of a misfolded conformer of the prion protein. We report that disease-associated prion protein specifically inhibits the proteolytic beta subunits of the 26S proteasome. Using reporter substrates, fluorogenic peptides, and an activity probe for the beta subunits, this inhibitory effect was demonstrated in pure 26S proteasome and three different cell lines. By challenge with recombinant prion and other amyloidogenic proteins, we demonstrate that only the prion protein in a normative beta sheet conformation inhibits the 26S proteasome at stoichiometric concentrations. Preincubation with an antibody specific for aggregation intermediates abrogates this inhibition, consistent with an oligomeric species mediating this effect. We also present evidence for a direct relationship between prion neuropathology and impairment of the ubiquitin-proteasome system (UPS) in prion-infected UPS-reporter mice. Together, these data suggest a mechanism for intracellular neurotoxicity mediated by oligomers of misfolded prion protein.
引用
收藏
页码:175 / 188
页数:14
相关论文
共 55 条
[1]   Pathway complexity of prion protein assembly into amyloid [J].
Baskakov, IV ;
Legname, G ;
Baldwin, MA ;
Prusiner, SB ;
Cohen, FE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21140-21148
[2]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[3]   Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib [J].
Berkers, CR ;
Verdoes, M ;
Lichtman, E ;
Fiebiger, E ;
Kessler, BM ;
Anderson, KC ;
Ploegh, HL ;
Ovaa, H ;
Galardy, PJ .
NATURE METHODS, 2005, 2 (05) :357-362
[4]   Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice:: exclusion of proteasome activator REGγ as a therapeutic target [J].
Bett, JS ;
Goellner, GM ;
Woodman, B ;
Pratt, G ;
Rechsteiner, M ;
Bates, GP .
HUMAN MOLECULAR GENETICS, 2006, 15 (01) :33-44
[5]   Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation [J].
Bowman, AB ;
Yoo, SY ;
Dantuma, NP ;
Zoghbi, HY .
HUMAN MOLECULAR GENETICS, 2005, 14 (05) :679-691
[6]   Normal host prion protein necessary for scrapie-induced neurotoxicity [J].
Brandner, S ;
Isenmann, S ;
Raeber, A ;
Fischer, M ;
Sailer, A ;
Kobayashi, Y ;
Marino, S ;
Weissmann, C ;
Aguzzi, A .
NATURE, 1996, 379 (6563) :339-343
[7]   MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE [J].
BUELER, H ;
AGUZZI, A ;
SAILER, A ;
GREINER, RA ;
AUTENRIED, P ;
AGUET, M ;
WEISSMANN, C .
CELL, 1993, 73 (07) :1339-1347
[8]   Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[9]   Prions and their partners in crime [J].
Caughey, Byron ;
Baron, Gerald S. .
NATURE, 2006, 443 (7113) :803-810
[10]   Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly [J].
Chen, P ;
Hochstrasser, M .
CELL, 1996, 86 (06) :961-972